2010; 63 (3):420–429.
Androgenetic alopecia (AGA) and its association with the metabolic syndrome (MetS) have received increasing interest since 1972, when the first link between cardiovascular risk factors and hair loss was raised. COVID-19 is an emerging, rapidly evolving situation.
Unable to load your collection due to an error
We have reviewed studies concerning the relationship between alopecia and MetS. The severity and prevalence increase with age in all races worldwide. Many studies have investigated the relationship among AGA and MetS and its individual components, particularly in men, where a disproportionately large number of these studies supports this association. Epub 2017 Jul 15.Medicine (Baltimore). Metabolic syndrome is important because it may confer an overall cardiovascular risk that is higher than the individual ... Gutiérrez-Salmerón MT, Castellote-Caballero L, Buendía-Eisman A, Naranjo-Sintes R. Androgenetic alopecia and cardiovascular risk factors in men and women: a comparative study.
… Hair loss is a common condition that affects most people at some point in their lives.
It can exist as an isolated problem or with other diseases and conditions. 2012 Mar;66(3):401-8. doi: 10.1016/j.jaad.2010.12.023.
AGA has also been associated with other metabolic-related conditions, including coronary artery disease, polycystic ovary syndrome, and Cushing syndrome, as well as several nutritional deficiencies, all of which have led to many clinicians advocating for the screening of MetS and cardiovascular risk factors in patients who present with AGA.We use cookies to help provide and enhance our service and tailor content and ads. PATIENTS SUBJECTS AND METHODS: This cross-sectional study included 400 … OBJECTIVE: To evaluate the incidence of benign prostatic hyperplasia (BPH) and metabolic syndrome in patients with androgenetic alopecia (AGA) in comparison with those with no AGA, as several previous studies have reported inconsistent results of an association between metabolic syndrome and BPH with AGA. 2019 Nov 20;10:788. doi: 10.3389/fendo.2019.00788.
Androgenetic alopecia is considered to be the most prevalent form of hair loss,1 and an interaction between genetic and environmental factors (including circulating androgens) is believed to be involved in its etiopathogenesis.2 Some studies have claimed that androgenetic alopecia may be associated with hypertension, metabolic syndrome, central obesity and other cardiovascular risk …
The increasing prevalence of Metabolic syndrome (MetS) is a worldwide health problem, and the association between MetS and skin diseases has recently attracted growing attention. 2017 Sep 12;8:688. doi: 10.3389/fphys.2017.00688.
This site needs JavaScript to work properly.
eCollection 2020.Front Endocrinol (Lausanne). In this review, we summarize the associations between MetS and skin diseases, such as psoriasis, acne vulgaris, hidradenitis suppurativa, androgenetic alopecia, acanthosis nigricans, and atopic dermatitis.
Elsevier Science 2004 Nov;296(6):245-9. doi: 10.1007/s00403-004-0514-z.Cannarella R, Condorelli RA, Mongioì LM, La Vignera S, Calogero AE.J Endocrinol Invest.
Background: Androgenetic alopecia (AGA) has a significant psychosocial impact on the patient, especially early-onset AGA patients. An association between metabolic syndrome and early-onset androgenic alopecia was seen; this may contribute to the predisposition of patients with androgenic alopecia to develop cardiovascular disease. [ 19] performed a meta-analysis and concluded that androgenic alopecia is a risk factor for metabolic syndrome and suggesting the patients with androgenic alopecia as a target group for screening of metabolic syndrome. Androgenetic alopecia (AGA) and its association with the metabolic syndrome (MetS) have received increasing interest since 1972, when the first link between cardiovascular risk factors and hair loss was raised. Name must be less than 100 characters eCollection 2019.Front Physiol.
Clipboard, Search History, and several other advanced features are temporarily unavailable. 23. 2016 May;95(19):e3243. Please enable it to take advantage of the complete set of features!
Arias-Santiago S, Arrabal-Polo MA, Buendía-Eisman A, Arrabal-Martín M, Gutiérrez-Salmerón MT, Girón-Prieto MS, Jimenez-Pacheco A, Calonje JE, Naranjo-Sintes R, Zuluaga-Gomez A, Serrano Ortega S.J Am Acad Dermatol.
By continuing you agree to the Copyright © 2020 Elsevier B.V. or its licensors or contributors. We have reviewed studies concerning the relationship between alopecia and MetS. 2020 Feb 5;13:137-143. doi: 10.2147/CCID.S231940. 2011; 65 (1):48–53.
This matter may be also concluded from our study.
Epub 2014 Mar 25.Arch Dermatol Res. Elsevier Science The metabolic syndrome (MetS) comprises a combination of interconnected physiological, biochemical, clinical, ... Naranjo-Sintes R. Sex hormone-binding globulin and risk of hyperglycemia in patients with androgenetic alopecia. “Metabolic syndrome” (MetS) is a combination of risk factors of cardiovascular and diabetes-related parameters.